J & J Snack Foods Reports Fiscal 2024 Fourth Quarter Revenue of $426.8 Million
Full Year Fiscal 2024 Revenue Increases 1.0% to $1.57 Billion; Gross Margin of 30.9% and Net Earnings of $86.6 Million […]
Canoo Inc. Announces Third Quarter 2024 Results
Quarterly revenue of $0.9 million, and year-to-date revenue of $1.50 million Quarterly Adjusted EBITDA was $(37.7) million, an improvement of […]
Stryve Foods, Inc. Reports Fiscal 2024 Third Quarter Results
36.4% Growth in Net Sales Year-over-YearGross Profit Up 122.1% versus Prior Year$2.9M in Gross Proceeds Raised to Support Growing Demand […]
SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update
– Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains […]
Hain Celestial To Participate in Upcoming Investor Conferences
HOBOKEN, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) — Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company […]
Dillard’s, Inc. to Report Third Quarter and Year-to-Date Results
LITTLE ROCK, Ark., Nov. 13, 2024 (GLOBE NEWSWIRE) — Dillard’s, Inc. (DDS: NYSE) will announce results for the 13 and […]
KULR Reports Record Revenue for the Third Quarter of 2024
HOUSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global […]
Victoria’s Secret & Co. Invites You to Listen to the Third Quarter 2024 Earnings Call Webcast
REYNOLDSBURG, Ohio, Nov. 13, 2024 (GLOBE NEWSWIRE) — In conjunction with the Victoria’s Secret & Co. (NYSE: VSCO) third quarter […]
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“NurExone” […]
Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates
Positive long-term extension data highlighting the differentiated profile of deucrictibant for the prevention and treatment of HAE attacks presented at […]
